Produktname:1-Methyl-1H-pyrazole-4-sulfonyl chloride

IUPAC Name:1-methyl-1H-pyrazole-4-sulfonyl chloride

CAS:288148-34-5
Molekulare Formel:C4H5ClN2O2S
Reinheit:95%+
Katalognummer:CM188010
Molekulargewicht:180.61

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM188010-10g in stock ŭƻœ
CM188010-25g in stock Əŭȋ
CM188010-100g in stock şşȋ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:288148-34-5
Molekulare Formel:C4H5ClN2O2S
Schmelzpunkt:-
SMILES-Code:O=S(C1=CN(C)N=C1)(Cl)=O
Dichte:
Katalognummer:CM188010
Molekulargewicht:180.61
Siedepunkt:
Mdl-Nr.:MFCD04968667
Lagerung:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Relacorilant
Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.